Name: Coronavirus Drug Remdesivir Received Emergency Approval By The FDA
Brand: buzzfeednews.com
SKU: buzzfeednews-com-153
Availability: OnlineOnly

critic

Coronavirus Drug Remdesivir Received Emergency Approval By The FDA

preview

The drug's approval comes days after a preliminary study showed a four-day decrease in hospital stays following treatment.BuzzFeed News has reporters across five continents bringing you trustworthy stories about the impact of the coronavirus. To help keep this news free, and sign up for our newsletter, .The FDA approved the experimental drug remdesivir for emergency use to treat on Friday, just days after a preliminary study reported it shortened hospital stays for COVID-19 patients.In an , the FDA's chief scientist, Denise Hinton, concluded, "It is reasonable to believe that the known and potential benefits of [remdesivir] outweigh the known and potential risks of the drug for the treatment of patients hospitalized with severe COVID-19." came just two days after the report of . In an experiment on 1,063 patients, the study found that while the drug did not statistically reduce mortality in COVID-19 patients, it did lead to a median hospital stay of 11 days rather than 15 for patients who received a placebo.News of the approval came from President Donald Trump in on Friday with the CEO of Gilead Sciences, the drug's maker. Remdesivir is an antiviral drug that interferes with the reproduction of viruses in cells, originally intended to treat the MERS and SARS coronaviruses."I think this really illustrates what can happen in such a short time," said Deborah Birx of the White House coronavirus task force. of remdesivir in 237 patients published in the Lancet on Wednesday found no clinical benefits to treating COVID-19 patients with the drug; its use was halted because the drug caused a higher percentage of side effects. However, the study did show similar signs of shortening hospital stays, although not to a statistically significant extent. Both studies started in February."It is not just because of the reduction in time to hospital discharge that this is a big deal," Peter Jüni, a University of Toronto professor and the editor-in-chief of the journal Trials, told BuzzFeed News. "It is a big deal because it shows there's a way with drugs to influence the course of the disease." Jüni suggested that larger clinical trials will show when during an infection patients will benefit the most from infusion with the drug.Possible side effects of remdesivir include nausea, low blood pressure, and an increase in liver enzymes associated with inflammation or damage to the organ, .The emergency use approval for remdesivir is the second one issued for a drug to treat COVID-19, the for hydroxychloroquine phosphate and chloroquine sulfate. The FDA issued a warning a month later of the drugs after more than a dozen patients died in a small clinical trial in Brazil.Your weekday morning guide to breaking news, cultural analysis, and everything in between

The drug's approval comes days after a preliminary study showed a four-day decrease in hospital stays following treatment.BuzzFeed News has reporters across five continents bringing you trustworthy stories about the impact of the coronavirus. To help keep this news free, and sign up for our newsletter, .The FDA approved the experimental drug remdesivir for emergency use to treat on Friday, just days after a preliminary study reported it shortened hospital stays for COVID-19 patients.In an , the FDA's chief scientist, Denise Hinton, concluded, "It is reasonable to believe that the known and...

public

BuzzFeed News science desk in Washington D.C. Contact: dan.vergano@buzzfeed.com * Cover science and its consequences * Send secure tips --contact.buzzfeed.com

Dan Vergano

dvergano

Got something that needs 👀? Send us tips here:   http://tips.buzzfeednews.com. Support our reporting: http://bit.ly/2VkE9pK

buzzfeednews.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

Coronavirus Drug Remdesivir Received Emergency Approval By The FDA

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS